Last Updated: May 6, 2026

Profile for Slovenia Patent: 2487163


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Slovenia Patent: 2487163

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Detailed Analysis of the Scope, Claims, and Patent Landscape for Slovenia Patent SI2487163

Last updated: August 21, 2025


Introduction

Patent SI2487163 pertains to a specific pharmaceutical invention filed in Slovenia. As a member of the European Patent Office (EPO) and aligned with international patent standards, Slovenia’s national patent SI2487163 offers insights into the scope of the protected invention, its claims, and how it fits into the broader pharmaceutical patent landscape. This analysis aims to elucidate the patent’s territorial scope, claim structure, inventive focus, and its position within global patent trends.


Scope of Patent SI2487163

Jurisdiction and Territorial Rights

Patent SI2487163 is a Slovenian national patent, providing patent protection exclusively within Slovenia. Its scope is limited territorially, but it can serve as a basis for subsequent national filings or a stepping stone in European or international patent applications (e.g., via the EPC or PCT routes). The patent grants exclusive rights to the patent holder within Slovenia to manufacture, use, sell, or license the claimed invention.

Subject Matter Coverage

The patent pertains to a pharmaceutical composition, possibly involving a novel therapeutic agent, a unique formulation, or a method of use. Patent scope encompasses the specific claims, which define the precise boundaries of patent protection. The scope is usually detailed in the claims section and may include:

  • Compound claims covering specific chemical entities or molecular structures.
  • Method claims describing particular processes, administration methods, or therapeutic indications.
  • Formulation claims related to specific compositions, excipients, or delivery systems.

The precise scope depends on these claims, which determine the breadth and strength of the protection.


Claims Analysis

Claim Structure and Hierarchy

Patent claims are the legal definition of the invention’s scope. They are typically categorized as:

  • Independent claims: Broadest, establishing core inventive features.
  • Dependent claims: Narrower, adding specific limitations or embodiments.

In SI2487163, the initial claims likely define the active compound or composition at a molecular level, specifying structural features, purity levels, or formulation parameters. Subsequent dependent claims refine these, often including specific dosages, methods of administration, or synergistic combinations.

Scope and Breadth of the Claims

  • Chemical Composition Claims: If the patent concentrates on a novel compound, claims would encompass the chemical structure, stereochemistry, polymorphs, or salts of the active ingredient.

  • Method of Use Claims: These would specify therapeutic applications, such as treating specific diseases (e.g., cancer, autoimmune disorders) using the compound or composition.

  • Formulation and Delivery Claims: Claims might also encompass formulations designed to enhance stability, bioavailability, or patient compliance.

Claim Language and Potential Limitations

Effective claims are precise yet broad enough to prevent workarounds. In pharmaceutical patents, overly narrow claims may be vulnerable to infringement by minor modifications, whereas overly broad claims risk invalidation for lack of inventive step or clarity.

In SI2487163, typical claims might specify novel chemical structures with certain substituents, unique synthesis routes, or specific therapeutic indications—crafted to maximize protection while maintaining novelty and inventive step.

Claim Validity Considerations

  • Novelty: The claims must describe an invention not previously disclosed.
  • Inventive step: The claims should involve a non-obvious improvement over prior art.
  • Industrial applicability: The invention needs to be useful and applicable in manufacturing or therapy.

Given the stringent criteria in Slovenia and EPO standards, the claims are likely carefully crafted to align with these requirements.


Patent Landscape and Related Intellectual Property

Position in the Pharmaceutical Patent Landscape

The patent landscape surrounding SI2487163 involves:

  • Prior Art Searches: Prior art within global databases, including patent repositories like Espacenet, the European Patent Register, and WIPO PATENTSCOPE, informs the patent’s novelty claim.
  • Related Patents and Applications: Similar patents may exist focusing on the same chemical class, therapeutic mechanism, or delivery system.

Competitive Technologies and Patent Clusters

  • Chemical Class and Therapeutic Area: If the invention involves a specific chemical class—such as kinase inhibitors, monoclonal antibodies, or peptide therapeutics—it will be part of a larger patent cluster. A thorough patent landscaping report would identify key players and patent portfolios in these clusters.

  • Patent Strategies: Commercial entities may file narrow ‘composition of matter’ patents alongside broad method claims to secure comprehensive protection.

Infringement and Freedom-to-Operate (FTO)

  • Companies must assess whether the SI2487163 claims overlap with their existing patents, especially if they operate within similar chemical or therapeutic domains.
  • The narrowness or breadth of claims determines the ease or difficulty of designing around the patent.

European and Global Patent Extensions

While SI2487163 restricts protection to Slovenia, strategies often involve filing in larger markets (e.g., via the European Patent Convention or the Patent Cooperation Treaty) to extend protection. The patent family likely includes applications in other jurisdictions.


Legal and Commercial Implications

  • Patent Enforcement: In Slovenia, patent holders can enforce rights via local courts, including injunctions and damages.
  • Market Exclusivity: Patent protection delays competition, enabling higher pricing strategies in Slovenia.
  • Innovation Incentives: Strong patent claims incentivize R&D by providing carve-outs in competitive markets.

Conclusion

Patent SI2487163 delineates a carefully tailored scope focusing on specific pharmaceutical compositions or methods within Slovenia. Its claim architecture balances breadth and precision to maximize protection while maintaining validity. Within the global pharma patent landscape, it exists as part of an intricate web of prior art, potential patent families, and competitive strategies aimed at monopolizing novel therapeutics.


Key Takeaways

  • Scope and Claims: The patent’s protections hinge on detailed claims covering chemical structures, formulations, or therapeutic methods, with the scope defined by claim language and hierarchy.
  • Broader Patent Landscape: SI2487163 fits into a complex patent ecosystem, with potential family counterparts and related patents targeting similar chemical classes or indications.
  • Strategic Importance: The patent provides exclusive rights within Slovenia, which can be pivotal for market entry, licensing, or further R&D investment.
  • Risk and Opportunity: Effective claim drafting enhances enforceability; understanding the landscape reduces infringement risks and guides licensing strategies.
  • Global Considerations: To maximize market protection, companies should pursue patent extensions into other key jurisdictions based on this patent family.

FAQs

Q1: How does Slovenian patent SI2487163 compare in scope to European patents in the same field?
A1: While SI2487163 offers protection solely within Slovenia, European patents (via the EPO) can provide broader protection across multiple countries, often with similar claim structures. The Slovenian patent may complement or be part of a European patent family.

Q2: Can the claims of SI2487163 be challenged for validity?
A2: Yes. Challenges can be made based on novelty or inventive step deficiencies, especially if prior art disclosures or obvious modifications exist within the claim scope.

Q3: How does the patent landscape influence research and development strategies?
A3: A dense patent landscape may encourage companies to design around existing patents or seek licensing. It also guides R&D toward novel, non-infringing innovations.

Q4: What are the risks of patent infringement in the pharmaceutical sector?
A4: Infringement can lead to costly legal battles, injunctions, or damages. Thorough patent clearance and landscape analyses mitigate these risks.

Q5: Is patent SI2487163 extendable or patentable in other jurisdictions?
A5: Yes. The applicant can file corresponding applications under international treaties like the PCT or directly in other jurisdictions to seek wider protection.


Sources:
[1] European Patent Office, Patent family information and patent landscapes.
[2] WIPO PatentScope database, for global patent applications.
[3] Slovenian Patent Office, official patent records and legal guidelines.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.